ANI Pharmaceuticals Completes Acquisition of Alimera Sciences, Expanding Rare Disease and Ophthalmology Portfolio

Strengthens Rare Disease segment as largest driver of future growth, adding approximately $105 million in 2024 revenue on a pro forma basis Adds two d...

September 17, 2024 | Tuesday | News
Eli Lilly Opens 346,000 sq. ft. Seaport Innovation Center as New Hub for Genetic Medicine and East Coast Gateway Labs

Lilly Seaport Innovation Center (LSC) serves as the central hub for Lilly's genetic medicines efforts and houses the first East Coast Lilly Gateway Labs ...

August 14, 2024 | Wednesday | News
BioSenic Secures Key Japanese Patent for Enhanced Arsenic-Based Therapeutics in Autoimmune and Cancer Treatments

Composition-of-matter patent covers the therapeutic use of arsenic salts and metal ions through various routes of administration. Enriched IP portfoli...

August 14, 2024 | Wednesday | News
Kyowa Kirin International Partners with NewBridge Pharmaceuticals to Distribute Rare Disease Treatments in Middle East and North Africa

Agreement will see NewBridge Pharmaceuticals act as a multi-country distributor in four countries across the Middle East and North Africa (MENA) ...

August 07, 2024 | Wednesday | News
Thermo Fisher Scientific's SeCore™ CDx HLA A Sequencing System Receives FDA Clearance as Companion Diagnostic for Adaptimmune’s TECELRA® TCR Therapy

Thermo Fisher Scientific Inc., the world leader in serving science,  announced that its SeCore™ CDx HLA A Sequencing System has been granted 5...

August 07, 2024 | Wednesday | News
NOVIO's INO-3107 Achieves EMA Certification for Recurrent Respiratory Papillomatosis Treatment

NOVIO a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related disease...

July 26, 2024 | Friday | News
Lario Therapeutics Receives $6 Million Grant from MJFF for Innovative Parkinson’s Disease Research

Award supports preclinical research of Lario’s CaV2.3 calcium channel inhibitors as a novel disease-modifying approach for treatment of Par...

July 23, 2024 | Tuesday | News
AstraZeneca Completes Acquisition of Amolyt Pharma for $1.05 Billion

  Amolyt Pharma, a global, clinical-stage biopharmaceutical company specializing in developing therapeutic peptides for rare endocrine and related di...

July 15, 2024 | Monday | News
Eli Lilly to Acquire Morphic Holding for $3.2 Billion, Expanding Gastroenterology Portfolio

Eli Lilly and Company (NYSE: LLY) and Morphic Holding, Inc. (NASDAQ: MORF)  announced a definitive agreement for Lilly to acquire Mor...

July 09, 2024 | Tuesday | News
Bio-Rad Launches Celselect Slides 2.0 to Enhance Rare Cell and CTC Capture

Bio-Rad Laboratories,  a global leader in life science research and clinical diagnostics products, today announced the launch of Celselect Slides 2....

July 01, 2024 | Monday | News
ANEW Medical Explores Pioneering Therapeutics and Diagnostics with Secreted Klotho Proteins

ANEW to explore therapeutics and specialty diagnostics utilizing the s-KL protein and will pursue other medical product development and commercial oppo...

June 26, 2024 | Wednesday | News
Essential Pharma Partners with AGC Biologics for Late-Phase Manufacturing of Promising Neuroblastoma Immunotherapy

Essential Pharma reaches agreement with AGC Biologics for late phase clinical manufacturing of its immunotherapy candidate for the treatment of high-risk...

June 11, 2024 | Tuesday | News
FDA Launches START Program to Accelerate Rare Disease Drug Development

START is a pilot program newly launched jointly by the FDA CDER and CBER divisions to further accelerate the development of novel drug and biological p...

June 03, 2024 | Monday | News
NKGen Biotech's SNK01 NK Cell Therapy Clears FDA IND Hurdle for Parkinson’s

The Company expects to initiate a Phase 1 clinical trial in PD in 2H 2024. NKGen Biotech, Inc. , a clinical-stage biotechnology company focused on the dev...

April 30, 2024 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close